Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. — CFSMEATLAS
Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome.
This study describes a teenage girl with ME/CFS who had damage to her gut lining, allowing bacterial toxins to leak into her bloodstream. When she was treated with antioxidants, dietary changes to repair her gut, and immune support therapy, the leaky gut improved and her ME/CFS symptoms disappeared. The findings suggest that gut damage may play a role in some ME/CFS cases.
Why It Matters
This case suggests a potential biological mechanism linking intestinal dysfunction to ME/CFS symptoms, which could guide future treatment approaches targeting gut health. If intestinal permeability contributes to ME/CFS in a subset of patients, it opens avenues for personalized diagnostic testing and targeted interventions beyond symptom management.
Observed Findings
Elevated serum IgM and IgA antibodies against gram-negative enterobacterial endotoxins (LPS), indicating increased gut permeability
Presence of oxidative and nitrosative stress markers
Activation of inflammatory response system
IgG3 subclass deficiency
Complete remission of ME/CFS symptoms following combination treatment
Inferred Conclusions
Intestinal mucosal dysfunction with increased endotoxin translocation may contribute to ME/CFS pathophysiology in this patient
Combined antioxidant, dietary, and immunoglobulin therapy may normalize gut permeability and resolve CFS symptoms
Multiple biological abnormalities (oxidative stress, inflammation, immune deficiency) may converge in ME/CFS pathogenesis
Remaining Questions
Does leaky gut and increased endotoxin translocation occur in a significant proportion of ME/CFS patients, or is this an isolated case?
Which component of the treatment regimen (antioxidants, diet, or immunoglobulins) was most critical for the patient's remission?
Can these findings be replicated in controlled trials with larger patient populations?
What This Study Does Not Prove
This single case report cannot prove that leaky gut causes ME/CFS or that this treatment works for all patients with the condition. The temporal relationship between treatment and remission does not establish causation, as spontaneous remission or placebo effects could explain the outcome. The findings are not generalizable and require validation through controlled clinical trials.